In compliance with current regulations, let us know which audience you belong to:
LM® LLLT
Light Modulation®
The power of light, cubed.
—LM® LLLT
LM® Low-level Light Therapy is a unique, light-based photobiomodulation technology. We developed and patented for medical use the technology originally employed by NASA (i.e., Low-level Laser Therapy) to treat wounds of astronauts in space.
LM® LLLT has nothing to do with Red Light Therapy (RLT), which only acts on the surface of the dermis—instead, LM® LLLT works at biological level, generating endogenous heat through powerful LEDs stimulating ATP production in cells.
Discover the Science behind LM® LLLT
A technology
Like no other.
Photobiomodulation therapy with LM® LLLT is a unique and completely painless form of near-infrared light therapy (NILT), highly effective for treating a broad spectrum of conditions. Our patented photobiomodulation technology leverages various wavelengths—red, blue, yellow, and infrared*—to cater to diverse medical needs.
In ophthalmology, it addresses both anterior (DED, Chalazion) and posterior (dAMD) segment conditions. Additionally, LM® LLLT extends its benefits to dermatology and trichology, ensuring versatile and effective outcomes by stimulating ATP production.
Maximum convenience,
exceptional value.
The degree of simplicity offered by LM® LLLT technology to the operator, and the convenience hence provided to the patient benefitting from its therapy is, put simply, unmatched. This, paired with LM® LLLT exceptional efficacy in addressing a broad spectrum of anterior and posterior segment conditions, along with dermatologic and trichologic concerns, makes it a true game-changer.
Science told us.
It just works.
LM® LLLT has recently been studied in a piece of research that compared it directly against IPL. The study has confirmed the efficacy of LM® LLLT, proving also its superior performance against traditional IPL technologies.
Another recent scientific paper has confirmed that LM® LLLT, employed jointly with OPE® IPL, is the key factor in effectively managing the most severe cases of recalcitrant MGD-induced DED and other ocular surface diseases.
Beyond treatments, enhancing cataract and refractive surgery routines.
LM® LLLT’s potential extends beyond direct treatment of most ocular surface diseases, playing a crucial role in both cataract and refractive surgeries. Literature indicates that unresolved ocular surface disease (OSD) is a major risk factor for suboptimal outcomes in these surgeries (Labetoulle M. Et Al, 2019). That’s why the Espansione Ecosystem, above all through LM® LLLT, is the best option to elevate your surgery routine.
No pain
Extreme gains.
Operators and patients can enjoy the unique benefits of LM® LLLT technology.
- ① It’s fast
- ② It’s painless
- ③ It grants immediate relief
- ④ It’s easy and safe
- ⑤ It’s plug&play